Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study.
Gold R, Comi G, Palace J, Siever A, Gottschalk R, Bijarnia M, von Rosenstiel P, Tomic D, Kappos L, For the FIRST Study Investigators
J Neurol. 2013 Nov 13. Epub 2013 Nov 13. PMID: 24221641.Abstract